January 29, 2015 6:23 AM ET


Company Overview of Gilead Pharmasset LLC

Company Overview

Gilead Pharmasset LLC, a clinical-stage pharmaceutical company, engages in discovering, developing, and commercializing novel drugs to treat viral infections. The company primarily focuses on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection. Nucleoside/tide analogs are a class of compounds, which act as alternative substrates for the viral polymerase, inhibiting viral replication. The company has three clinical stage product candidates, including PSI-7977, an uracil nucleotide analog polymerase inhibitor, which is initiating a Phase III clinical trials; PSI-938, a guanine nucleotide analog polymerase inhibitor that...

303-A College Road East

Princeton, NJ 08540

United States

Founded in 2004

82 Employees





Key Executives for Gilead Pharmasset LLC

President and Director
Age: 53
Chief Financial Officer and Director
Age: 51
Chief Scientific Officer and Executive Vice President of Pharmaceutical Research
Age: 65
Chief Medical Officer
Age: 47
Senior Vice President of Business Development & Scientific Affairs
Age: 51
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Tissue Genesis, Inc. United States
Neogenix Oncology, Inc. United States
Tolerance Therapeutics LLC United States
Nortis Inc. United States
Celgene Avilomics Research, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Gilead Pharmasset LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.